CVS stock fundamentals - cash flow
Cash Flow
- capital Expenditures --984,000,000
- cash Change 17,720,000,000
- cash Flow 7,438,000,000
- cash Flow Financing 2,726,000,000
- changes In Inventories 18,263,000,000
- changes In Receivables 28,331,000,000
- currency USD
- depreciation 1,001,000,000
- filing Type 10-Q
- fiscal Date 2023-03-31
- fiscal Quarter 1
- fiscal Year 2023
- fiscal Year 2023
- net Borrowings 36,741,000,000
- net Income 2,136,000,000
- report Date 2023-05-03
- symbol CVS
- total Investing Cash Flows --8,514,000,000
- id CASH_FLOW
- key CVS
- subkey quarterly
- date 2023-03-31
- updated 2023-05-11
Related News

Can NYSE:TSM Hit $212 as AI Chip Demand Skyrockets in 2025?
TradingNEWS Archive
21.04.25

NASDAQ:NFLX Surges to $1095—But Can It Justify a $1 Trillion Valuation Amid Recession Fears?
TradingNEWS Archive
21.04.25

NASDAQ:TSLA Plunges to $148—But Is This the Most Undervalued Tech Giant of 2025?
TradingNEWS Archive
21.04.25

NASDAQ:AMD Crashes to $89—But $2B Oracle AI Deal Hints at Massive Comeback
TradingNEWS Archive
18.04.25